Search
for
Sort by
Research 151–180 of 1000+
- Ciliary Madarosis Secondary to Intra-Arterial Chemotherapy for Retinoblastoma Treatment
- 40194 Polycystic Ovary Syndrome Diagnosis Does Not Predict Increased Hidradenitis Suppurativa Disease Severity
- #6180 OXALATE NEPHROPATHY SECONDARY TO ENTERIC HYPEROXALURIA: A RARE CAUSE OF END STAGE RENAL FAILURE – A REPORT OF 2 CASES
- Abstract 2205: KRTAP 2-3 is a novel potential biomarker of cells in the polyaneuploid cancer cell (PACC) state to predict cancer recurrence
- Trichoscopic Aspects of Alopecia Areata in Children: A Series of 30 Cases
- Elevated Mammalian Target of Rapamycin (mTOR) Gene Expression in Acne Vulgaris patients
- A Paediatric Case of Severe Allergic Conjunctivits with Underlying Alopecia Areata
- Sertoliform Endometrioid Carcinomas of the Right Ovary
- Trichoscopy I: Non-Cicatricial Alopecia
- Untargeted Metabolomic Approach to Study the Serum Metabolites in Women with Polycystic Ovary Syndrome
- Focal Asymptomatic Hair Loss in an Adolescent: A Case Report
- Non‐endocrine alopecia
- Telogen Effluvium
- Observational study on risk factors, complications and management of polycystic ovarian syndrome
- Pancreatic cancer
- Inflammatory and non-melanocytic tumoral pathology of the nail
- Unusual Cause of Chronic Diarrhea: Cronkhite-Canada Syndrome
- Telogeen effluvium
- C001 Lymphoproliferative disorders
- Alopecia Areata and Regrowth of Hair
- Characters of KRT80 and its roles in neoplasms diseases
- The Coexistence of Trachyonychia and Mucocutaneous Lichen Planus: A Case Report
- Beyond the Matrix: A Rare Case of Pilomatrix Carcinoma with Histologic Insights
- Diagnosis dan Tata Laksana Graves’ Disease
- Case 3
- Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: A retrospective cohort study from Taiwan
- Hyperadrenocorticism (Hyperadrenocorticoidism, Hyperadrenocorticalism, Cushing’s Disease, Cushing’s Syndrome)
- Hormones and COVID-19
- S1‐Guideline Cutaneous Angiosarcomas – Update 2021
- KRT17: A Key Driver of Cancer Therapy Resistance and Emerging Therapeutic Target